Clinical Aspects of Iron Use in the Anemia of Kidney Disease
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Iron deficiency occurs in the vast majority of patients with chronic kidney disease (CKD). The causes of iron deficiency in these patients are multifactorial. Main factors that contribute to iron deficiency in patients with end-stage renal disease (ESRD) are reduced intake and impaired intestinal
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Assessing Iron Status: Beyond Serum Ferritin and Transferrin Saturation
Wish, J. B. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01490506 · Cited by 556
Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease
Agarwal, R., Vasavada, N., Sachs, N. G., & Chase, S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00648.x · Cited by 261 · cited 2×
“(101) administered 100 mg of iron sucrose over 5 min, whereas Macdougall and Roche (136) found that administration of 200 mg of iron sucrose as an intravenous bolus injection of 2 min is a practical dosing regimen in patients with CKD, but seven patients experienced hypotensive reactions under these conditions.”
BackgroundPatruta, S. I., Edlinger, R., Sunder-Plassmann, G., & Hörl, W. H. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v94655 · Cited by 182
Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo
Rooyakkers, T. M., Stroes, E. S. G., Kooistra, M. P., Van Faassen, E. E., Hider, R. C., Rabelink, T. J., & Marx, J. J. M. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.0320s1009.x · Cited by 157 · cited 2×
“In normal volunteers, free iron release was associated with increased reactive oxygen species in plasma and reduced flow-mediated forearm blood flow (113).”
BackgroundDiagnosis of iron deficiency in chronic renal failure
Fernández-Rodríguez, A. M., Guindeo-Casasús, M. C., Molero-Labarta, T., Domínguez-Cabrera, C., Hortal-Cascón, L., Pérez-Borges, P., Vega-Díaz, N., Saavedra-Santana, P., & Palop-Cubillo, L. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70079-x · Cited by 126
Weiss, G., Meusburger, E., Radacher, G., Garimorth, K., Neyer, U., & Mayer, G. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00099.x · Cited by 105 · cited 4×
“In contrast, ESA dosage decreased with the increase of IL-4 and the decrease in TNF- (97).”
BackgroundInfluential
Cited by
Erythropoietic response and outcomes in kidney disease and type 2 diabetes
Solomon, S. D., Uno, H., Lewis, E. F., Eckardt, K.-U., Lin, J., Burdmann, E. A., de Zeeuw, D., Ivanovich, P., Levey, A. S., Parfrey, P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005109 · Cited by 473
Shepshelovich, D., Rozen-Zvi, B., Avni, T., Gafter, U., & Gafter-Gvili, A. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.04.018 · Cited by 322
2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease
Tsubakihara, Y., Nishi, S., Akiba, T., Hirakata, H., Iseki, K., Kubota, M., Kuriyama, S., Komatsu, Y., Suzuki, M., Nakai, S., et al. (2010) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2010.00836.x · Cited by 278
Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st Century
Rostoker, G., Vaziri, N. D., & Fishbane, S. (2016) · Drugs · doi:10.1007/s40265-016-0569-0 · Cited by 71
“Finally, data on the effect of iron infusion on LIC in dialysis patients studied by MRI are scarce: only one Australian study reported a mean LIC increase of 25.4 lmol/g dry weight on R2 relaxometry, 2 weeks after infusion of 10–20 mg/kg iron polymaltose (Maltofer ) to 25 CKD patients, of whom five were on dialysis; t…”
BackgroundInfluentialSonnweber, T., Theurl, I., Seifert, M., Schroll, A., Eder, S., Mayer, G., & Weiss, G. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq483 · Cited by 55
Metadata
- Authors
- Hörl, W. H.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2007-02
- Volume
- 18
- Issue
- 2
- Pages
- 382-393
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2129563567
- Cited by
- 152
- References
- 7
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.